Regulatory uncertainty is weighing on the valuation of UBS and other European lenders and the Swiss bank's integration of its ...
CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback